This tax season, the Australian Cancer Research Foundation (ACRF) has partnered with tax accountants, H&R Block to deliver an online calculator that tells individuals how much tax they will receive back from their donation, as well as exactly what their donation has the capacity to fund.
The creative concept and implementation of the calculator was all thanks to pro-bono work done by M&C Saatchi’s creative team.
“We hope that by being transparent and showing donors how much influence even a small donation can have on the work that’s being done in cancer research, it will help them understand how truly valuable their support is,” commented Professor Ian Brown, CEO of the ACRF.
Last year, donations to the ACRF went towards equipment that is being used to further develop personalised cancer treatments, detect lung cancer before it spreads, and examine native Australian plants to see if they can be used to develop new cancer treatments.
The ACRF has been a driving force behind cancer research for over 30 years. However, with success rates now less than 14 percent for applications to grants from the National Health and Medical Research Council, the organisation is keen to do all it can to increase the availability of vital funding.
Advancements in technology are allowing researchers to analyse data like never before. But such technology is difficult to get funding for. The ACRF is the only national charity in Australia whose sole purpose is to make advanced equipment and technology more accessible to Australian cancer researchers, regardless of the type of cancer they study. This is helping prevent the best and brightest scientists from moving elsewhere or changing jobs.
The support of H&R Block, as well as other corporate partners, continues to help ACRF provide the sector with the lifeline that it needs.
“At H&R Block we value the health and wellbeing of all Australians, so we’re proud to assist ACRF in its goal to deliver the highest impact in an area of vital need. Too many people are suffering from the effects of cancer, so being even a small part of the solution is both humbling and gratifying,” said Brodie Dixon, managing director of H&R Block.